Decheng Capital Management III (Cayman)’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $3.59M | Hold |
714,285
| – | – | 1.2% | 18 |
|
2023
Q2 | $6.25M | Hold |
714,285
| – | – | 1.96% | 12 |
|
2023
Q1 | $8.46M | Hold |
714,285
| – | – | 3.41% | 11 |
|
2022
Q4 | $7.27M | Hold |
714,285
| – | – | 2.72% | 12 |
|
2022
Q3 | $4.21M | Hold |
714,285
| – | – | 1.53% | 17 |
|
2022
Q2 | $1.77M | Hold |
714,285
| – | – | 0.67% | 19 |
|
2022
Q1 | $2.12M | Buy |
+714,285
| New | +$2.12M | 0.65% | 20 |
|